Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


Articles published in J Cancer Res Clin Oncol

Retrieve available abstracts of 57 articles:
HTML format
Text format



Single Articles


    November 2017
  1. XIONG Y, Wang L, Wang S, Wang M, et al
    SIRT3 deacetylates and promotes degradation of P53 in PTEN-defective non-small cell lung cancer.
    J Cancer Res Clin Oncol. 2017 Nov 4. doi: 10.1007/s00432-017-2537.
    PubMed     Text format     Abstract available


  2. KIM HR, Kim SY, Kim CH, Yang SH, et al
    Sex-specific incidence of EGFR mutation and its association with age and obesity in lung adenocarcinomas: a retrospective analysis.
    J Cancer Res Clin Oncol. 2017;143:2283-2290.
    PubMed     Text format     Abstract available


    October 2017
  3. WEI S, Tian J, Song X, Wu B, et al
    Causes of death and competing risk analysis of the associated factors for non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database.
    J Cancer Res Clin Oncol. 2017 Oct 4. doi: 10.1007/s00432-017-2522.
    PubMed     Text format     Abstract available


    September 2017
  4. MEIER-SCHROERS M, Homsi R, Skowasch D, Buermann J, et al
    Lung cancer screening with MRI: results of the first screening round.
    J Cancer Res Clin Oncol. 2017 Sep 20. doi: 10.1007/s00432-017-2521.
    PubMed     Text format     Abstract available


  5. THULER LCS, Costa GJ, de Mello MJG, Ferreira CG, et al
    Response to "Commentary on: Undertreatment trend in elderly lung cancer patients in Brazil"-Jing-lan Tang, Chun-jie Hou.
    J Cancer Res Clin Oncol. 2017 Sep 5. doi: 10.1007/s00432-017-2511.
    PubMed     Text format    


  6. TAO H, Zhang Y, Li Q, Chen J, et al
    Methodological quality evaluation of systematic reviews or meta-analyses on ERCC1 in non-small cell lung cancer: a systematic review.
    J Cancer Res Clin Oncol. 2017 Sep 5. doi: 10.1007/s00432-017-2516.
    PubMed     Text format     Abstract available


    August 2017
  7. TANG JL, Hou CJ
    Commentary on: undertreatment trend in elderly lung cancer patients in Brazil.
    J Cancer Res Clin Oncol. 2017 Aug 29. doi: 10.1007/s00432-017-2498.
    PubMed     Text format    


  8. GU C, Wang R, Pan X, Huang Q, et al
    Sublobar resection versus lobectomy in patients aged </=35 years with stage IA non-small cell lung cancer: a SEER database analysis.
    J Cancer Res Clin Oncol. 2017 Aug 17. doi: 10.1007/s00432-017-2499.
    PubMed     Text format     Abstract available


  9. LIAO YH, Li CI, Lin CC, Lin JG, et al
    Traditional Chinese medicine as adjunctive therapy improves the long-term survival of lung cancer patients.
    J Cancer Res Clin Oncol. 2017 Aug 12. doi: 10.1007/s00432-017-2491.
    PubMed     Text format     Abstract available


  10. MININA VI, Soboleva OA, Glushkov AN, Voronina EN, et al
    Polymorphisms of GSTM1, GSTT1, GSTP1 genes and chromosomal aberrations in lung cancer patients.
    J Cancer Res Clin Oncol. 2017 Aug 2. doi: 10.1007/s00432-017-2486.
    PubMed     Text format     Abstract available


  11. HASHIMOTO H, Suda Y, Miyashita T, Ochiai A, et al
    A novel method to generate single-cell-derived cancer-associated fibroblast clones.
    J Cancer Res Clin Oncol. 2017;143:1409-1419.
    PubMed     Text format     Abstract available


    May 2017
  12. WU X, Ma W, Zhou Q, Yan H, et al
    AXL-GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases.
    J Cancer Res Clin Oncol. 2017 May 27. doi: 10.1007/s00432-017-2408.
    PubMed     Text format     Abstract available


    April 2017
  13. WIECZOREK SA, Breitenbuecher F, Soni A, Paul-Konietzko K, et al
    Deregulated BCL-2 family proteins impact on repair of DNA double-strand breaks and are targets to overcome radioresistance in lung cancer.
    J Cancer Res Clin Oncol. 2017 Apr 21. doi: 10.1007/s00432-017-2427.
    PubMed     Text format     Abstract available


  14. COSTA GJ, de Mello MJ, Ferreira CG, Thuler LC, et al
    Undertreatment trend in elderly lung cancer patients in Brazil.
    J Cancer Res Clin Oncol. 2017 Apr 7. doi: 10.1007/s00432-017-2412.
    PubMed     Text format     Abstract available


  15. TAO H, Tanaka T, Okabe K
    Doublecortin and CaM kinase-like-1 expression in pathological stage I non-small cell lung cancer.
    J Cancer Res Clin Oncol. 2017 Apr 5. doi: 10.1007/s00432-017-2405.
    PubMed     Text format     Abstract available


    March 2017
  16. HASTINGS RH, Montgrain PR, Quintana RA, Chobrutskiy B, et al
    Lung carcinoma progression and survival versus amino- and carboxyl-parathyroid hormone-related protein expression.
    J Cancer Res Clin Oncol. 2017 Mar 25. doi: 10.1007/s00432-017-2396.
    PubMed     Text format     Abstract available


  17. OLEKSIEWICZ U, Liloglou T, Tasopoulou KM, Daskoulidou N, et al
    COL1A1, PRPF40A, and UCP2 correlate with hypoxia markers in non-small cell lung cancer.
    J Cancer Res Clin Oncol. 2017 Mar 3. doi: 10.1007/s00432-017-2381.
    PubMed     Text format     Abstract available


    February 2017
  18. UDAGAWA H, Niho S, Kirita K, Umemura S, et al
    Impact of denosumab use on the survival of untreated non-squamous non-small cell lung cancer patients with bone metastases.
    J Cancer Res Clin Oncol. 2017 Feb 20. doi: 10.1007/s00432-017-2350.
    PubMed     Text format     Abstract available


  19. MIGLIORINO MR, Santo A, Romano G, Cortinovis D, et al
    Economic burden of patients affected by non-small cell lung cancer (NSCLC): the LIFE study.
    J Cancer Res Clin Oncol. 2017 Feb 18. doi: 10.1007/s00432-016-2326.
    PubMed     Text format     Abstract available


  20. KLUPCZYNSKA A, Derezinski P, Garrett TJ, Rubio VY, et al
    Study of early stage non-small-cell lung cancer using Orbitrap-based global serum metabolomics.
    J Cancer Res Clin Oncol. 2017 Feb 6. doi: 10.1007/s00432-017-2347.
    PubMed     Text format     Abstract available


  21. SHIMIZU K, Kirita K, Aokage K, Kojima M, et al
    Clinicopathological significance of caveolin-1 expression by cancer-associated fibroblasts in lung adenocarcinoma.
    J Cancer Res Clin Oncol. 2017;143:321-328.
    PubMed     Text format     Abstract available


  22. XIAO CZ, Wei W, Guo ZX, Zhang MY, et al
    MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.
    J Cancer Res Clin Oncol. 2017;143:263-273.
    PubMed     Text format     Abstract available


  23. GOTO M, Naito M, Saruwatari K, Hisakane K, et al
    The ratio of cancer cells to stroma after induction therapy in the treatment of non-small cell lung cancer.
    J Cancer Res Clin Oncol. 2017;143:215-223.
    PubMed     Text format     Abstract available


  24. DUARTE CW, Black AW, Lucas FL, Vary CP, et al
    Cancer incidence in patients with hereditary hemorrhagic telangiectasia.
    J Cancer Res Clin Oncol. 2017;143:209-214.
    PubMed     Text format     Abstract available


  25. NI JY, Xu LF, Wang WD, Huang QS, et al
    Transarterial embolization combined with RNA interference targeting hypoxia-inducible factor-1alpha for hepatocellular carcinoma: a preliminary study of rat model.
    J Cancer Res Clin Oncol. 2017;143:199-207.
    PubMed     Text format     Abstract available


    January 2017
  26. XU Y, Zhu C, Qian W, Zheng M, et al
    Comprehensive study of mutational and clinicopathologic characteristics of adenocarcinoma with lepidic pattern in surgical resected lung adenocarcinoma.
    J Cancer Res Clin Oncol. 2017;143:181-186.
    PubMed     Text format     Abstract available


    December 2016
  27. YAO S, Zhong L, Liu J, Feng J, et al
    Prognostic value of decreased GRK6 expression in lung adenocarcinoma.
    J Cancer Res Clin Oncol. 2016;142:2541-2549.
    PubMed     Text format     Abstract available


  28. DE FREITAS AC, Gurgel AP, de Lima EG, de Franca Sao Marcos B, et al
    Human papillomavirus and lung cancinogenesis: an overview.
    J Cancer Res Clin Oncol. 2016;142:2415-2427.
    PubMed     Text format     Abstract available


    September 2016
  29. CAI F, Zhu Q, Miao Y, Shen S, et al
    Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  30. ILAHI NE, Anwar S, Noreen M, Hashmi SN, et al
    Detection of human papillomavirus-16 DNA in archived clinical samples of breast and lung cancer patients from North Pakistan.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  31. ZHANG B, Wang J, Liu W, Yin Y, et al
    Cytokeratin 18 knockdown decreases cell migration and increases chemosensitivity in non-small cell lung cancer.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  32. HUBER JM, Amann A, Koeck S, Lorenz E, et al
    Evaluation of assays for drug efficacy in a three-dimensional model of the lung.
    J Cancer Res Clin Oncol. 2016;142:1955-66.
    PubMed     Text format     Abstract available


  33. LUO J, Huang Q, Wang R, Han B, et al
    Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB.
    J Cancer Res Clin Oncol. 2016;142:2031-40.
    PubMed     Text format     Abstract available


    August 2016
  34. MIN KW, Kim WS, Jang SJ, Choi YD, et al
    MassARRAY, pyrosequencing, and PNA clamping for EGFR mutation detection in lung cancer tissue and cytological samples: a multicenter study.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  35. LUO J, Wang R, Han B, Zhang J, et al
    Analysis of the clinicopathologic characteristics and prognostic of stage I invasive mucinous adenocarcinoma.
    J Cancer Res Clin Oncol. 2016;142:1837-45.
    PubMed     Text format     Abstract available


    July 2016
  36. DRZEWIECKA H, Galecki B, Jarmolowska-Jurczyszyn D, Kluk A, et al
    Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  37. HATA K, Yoshida J, Udagawa H, Hashimoto H, et al
    The difference in Ezrin-pAkt signaling axis between lepidic and papillary predominant invasive adenocarcinomas of the lung.
    J Cancer Res Clin Oncol. 2016;142:1421-30.
    PubMed     Text format     Abstract available


    June 2016
  38. KANAJI N, Tadokoro A, Kita N, Murota M, et al
    Impact of idiopathic pulmonary fibrosis on advanced non-small cell lung cancer survival.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  39. KATO T, Morise M, Ando M, Kojima E, et al
    Can we predict the development of serious adverse events (SAEs) and early treatment termination in elderly non-small cell lung cancer (NSCLC) patients receiving platinum-based chemotherapy?
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  40. ZHU H, Mi Y, Jiang X, Zhou X, et al
    Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
    J Cancer Res Clin Oncol. 2016;142:969-80.
    PubMed     Text format     Abstract available


  41. SEKIHARA K, Hishida T, Ikemura S, Saruwatari K, et al
    The association of intravascular stromal cells with prognosis in high-grade neuroendocrine carcinoma of the lung.
    J Cancer Res Clin Oncol. 2016;142:905-12.
    PubMed     Text format     Abstract available


    April 2016
  42. SUDA Y, Neri S, Hashimoto H, Higuchi Y, et al
    Clonal heterogeneity in osteogenic potential of lung cancer-associated fibroblasts: promotional effect of osteogenic progenitor cells on cancer cell migration.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  43. SUZUKI S, Aokage K, Hishida T, Yoshida J, et al
    Interstitial growth as an aggressive growth pattern in primary lung cancer.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  44. ZHENG D, Wang R, Zhang Y, Pan Y, et al
    Prevalence and clinicopathological characteristics of ALK fusion subtypes in lung adenocarcinomas from Chinese populations.
    J Cancer Res Clin Oncol. 2016;142:833-43.
    PubMed     Text format     Abstract available


    March 2016
  45. XU J, Zhang Y, Jin B, Chu T, et al
    Efficacy of EGFR tyrosine kinase inhibitors for non-adenocarcinoma lung cancer patients harboring EGFR-sensitizing mutations in China.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    February 2016
  46. FAN H, Shao ZY, Xiao YY, Xie ZH, et al
    Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  47. HASSAN WA, Yoshida R, Kudoh S, Motooka Y, et al
    Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  48. NERI S, Hashimoto H, Kii H, Watanabe H, et al
    Cancer cell invasion driven by extracellular matrix remodeling is dependent on the properties of cancer-associated fibroblasts.
    J Cancer Res Clin Oncol. 2016;142:437-46.
    PubMed     Text format     Abstract available


  49. ZHANG J, Deng YT, Liu J, Wang YQ, et al
    Norepinephrine induced epithelial-mesenchymal transition in HT-29 and A549 cells in vitro.
    J Cancer Res Clin Oncol. 2016;142:423-35.
    PubMed     Text format     Abstract available


    January 2016
  50. BADE M, Bahr V, Brandt U, Eigentopf A, et al
    Effect of smoking cessation counseling within a randomised study on early detection of lung cancer in Germany.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    December 2015
  51. KOHLER J, Schuler M, Gauler TC, Nopel-Dunnebacke S, et al
    Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.
    J Cancer Res Clin Oncol. 2015.
    PubMed     Text format     Abstract available


  52. MATSUMURA Y, Umemura S, Ishii G, Tsuta K, et al
    Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma.
    J Cancer Res Clin Oncol. 2015;141:2159-70.
    PubMed     Text format     Abstract available


  53. MORISE M, Hishida T, Takahashi A, Yoshida J, et al
    Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lung.
    J Cancer Res Clin Oncol. 2015;141:2121-30.
    PubMed     Text format     Abstract available


    November 2015
  54. SUNPAWERAVONG P, Thu KL, Lam WL, Mai S, et al
    Assessment of the clinical relevance of 17q25.3 copy number and three-dimensional telomere organization in non-small lung cancer patients.
    J Cancer Res Clin Oncol. 2015.
    PubMed     Text format     Abstract available


  55. ZHONG R, Ge X, Chu T, Teng J, et al
    Lentivirus-mediated knockdown of CTDP1 inhibits lung cancer cell growth in vitro.
    J Cancer Res Clin Oncol. 2015.
    PubMed     Text format     Abstract available


  56. GARNETT DJ
    Caveolae as a target to quench autoinduction of the metastatic phenotype in lung cancer.
    J Cancer Res Clin Oncol. 2015.
    PubMed     Text format     Abstract available


    May 2015
  57. CHEN H, Yu JW, Wu JG, Wang SL, et al
    Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
    J Cancer Res Clin Oncol. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: